Irbesartan

In the US, Irbesartan (irbesartan systemic) is a member of the drug class angiotensin II inhibitors and is used to treat Diabetic Kidney Disease and High Blood Pressure.

US matches:

• Irbesartan


• Irbesartan/Hydrochlorothiazide

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

C09CA04

CAS registry number (Chemical Abstracts Service)

0138402-11-6

Chemical Formula

C25-H28-N6-O

Molecular Weight

428

Therapeutic Categories

Antihypertensive agent

Angiotensin-II antagonist

Chemical Name

1,3-Diazaspiro[4.4]non-1-en-4-one, 2-butyl-3-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-

Foreign Names

• Irbesartanum (Latin)
• Irbesartan (German)
• Irbesartan (French)
• Irbesartan (Spanish)

Generic Names

• Irbesartan (OS: USAN, BAN)
• BMS 186295 (IS: Bristol-Myers)
• SR 47436 (IS: SanofiWinthrop)
• Irbesartan (PH: USP 32)

Brand Names

• Adana
  Sandoz, Argentina



• Aprovel
  Bristol-Myers Squibb, United Kingdom; Bristol-Myers Squibb, Iceland; Bristol-Myers Squibb, Portugal; Bristol-Myers Squibb, Romania; Sanofi, Luxembourg; Sanofi, Tunisia; Sanofi Aventis, Antigua & Barbuda; Sanofi Aventis, Netherlands Antilles; Sanofi Aventis, Aruba; Sanofi Aventis, Bermuda; Sanofi Aventis, Bahamas; Sanofi Aventis, China; Sanofi Aventis, Haiti; Sanofi Aventis, Jamaica; Sanofi Aventis, Cayman Islands; Sanofi Aventis, Saint Lucia; Sanofi Aventis, Trinidad & Tobago; Sanofi Aventis, Saint Vincent & The Grenadines; Sanofi Pharma, Denmark; Sanofi Pharma Bristol-Myers Squibb, Norway; Sanofi Winthrop, Bulgaria; Sanofi/Bristol-Myers Squibb, Switzerland; Sanofi-Aventis, Argentina; Sanofi-Aventis, Belgium; Sanofi-Aventis, Bahrain; Sanofi-Aventis, Brazil; Sanofi-Aventis, Belize; Sanofi-Aventis, Chile; Sanofi-Aventis, Colombia; Sanofi-Aventis, Costa Rica; Sanofi-Aventis, Germany; Sanofi-Aventis, Dominican Republic; Sanofi-Aventis, Ecuador; Sanofi-Aventis, France; Sanofi-Aventis, United Kingdom; Sanofi-Aventis, Greece; Sanofi-Aventis, Guatemala; Sanofi-Aventis, Hong Kong; Sanofi-Aventis, Honduras; Sanofi-Aventis, Croatia (Hrvatska); Sanofi-Aventis, Hungary; Sanofi-Aventis, Indonesia; Sanofi-Aventis, Ireland; Sanofi-Aventis, Iceland; Sanofi-Aventis, Italy; Sanofi-Aventis, Mexico; Sanofi-Aventis, Malaysia; Sanofi-Aventis, Nicaragua; Sanofi-Aventis, Netherlands; Sanofi-Aventis, Oman; Sanofi-Aventis, Panama; Sanofi-Aventis, Peru; Sanofi-Aventis, Philippines; Sanofi-Aventis, Romania; Sanofi-Aventis, Russian Federation; Sanofi-Aventis, Sweden; Sanofi-Aventis, Singapore; Sanofi-Aventis, Slovenia; Sanofi-Aventis, Slovakia; Sanofi-Aventis, El Salvador; Sanofi-Aventis, Thailand; Sanofi-Aventis, Taiwan; Sanofi-Aventis, Venezuela; Sanofi-Aventis, Vietnam; Sanofi-Aventis, South Africa; Sanofi-Aventis S.A.U., Spain; Sanofi-Synthelabo, Myanmar; Sanofi-Synthelabo, Portugal



• Arbit
  Beximco, Bangladesh



• Avalide (Irbesartan and Hydrochlorothiazide)
  Bristol-Myers Squibb, Canada; Bristol-Myers Squibb, United States; sanofi-aventis, Canada; sanofi-aventis, United States



• Avapro
  Bristol-Myers Squibb, Argentina; Bristol-Myers Squibb, Australia; Bristol-Myers Squibb, Brazil; Bristol-Myers Squibb, Canada; Bristol-Myers Squibb, Mexico; Bristol-Myers Squibb, United States; Dainippon Sumitomo, Japan; Sanofi-Aventis, United States



• Cavapro
  Unimed & Unihealth, Bangladesh



• Co Aprovel (Irbesartan and Hydrochlorothiazide)
  Sanofi-Aventis, Belgium; Sanofi-Aventis, Peru



• CoAprovel (Irbesartan and Hydrochlorothiazide)
  Bristol-Myers Squibb, France; Bristol-Myers Squibb, United Kingdom; Sanofi, Tunisia; Sanofi Aventis, China; Sanofi Pharma Bristol-Myers Squibb, Norway; Sanofi Winthrop, Bulgaria; Sanofi/Bristol-Myers Squibb, Switzerland; Sanofi-Aventis, Bahrain; Sanofi-Aventis, Germany; Sanofi-Aventis, Denmark; Sanofi-Aventis, United Kingdom; Sanofi-Aventis, Croatia (Hrvatska); Sanofi-Aventis, Hungary; Sanofi-Aventis, Indonesia; Sanofi-Aventis, Ireland; Sanofi-Aventis, Italy; Sanofi-Aventis, Netherlands; Sanofi-Aventis, Oman; Sanofi-Aventis, Sweden; Sanofi-Aventis, Singapore; Sanofi-Aventis, Slovenia; Sanofi-Aventis, Slovakia; Sanofi-Aventis, Thailand; Sanofi-Aventis, South Africa; Sanofi-Aventis S.A.U., Spain; Sanofi-Synthelabo, Bulgaria



• Ecard
  Jayson, Bangladesh



• Fritens
  Kalbe, Indonesia



• Ibsan
  Acme, Bangladesh



• Irbehasan 150/300
  Hasan, Vietnam



• Irbeprex
  Gotland, Colombia



• Irbes
  Eskayef, Bangladesh



• Irbesartan Caferma
  Caferma, Peru



• Irbesartan Grey Inversiones
  Grey Inversiones, Peru



• Irbesartan Krka
  Krka, Slovakia



• Irbesartan Miklich
  krka, Bulgaria



• Irbesartan Sandoz
  Sandoz, Switzerland; Sandoz, Colombia; Sandoz, Costa Rica; Sandoz, Guatemala; Sandoz, Nicaragua; Sandoz, Panama; Sandoz, El Salvador



• Irbesartan
  Stada, Vietnam



• Irbesel
  Caferma, Peru



• Irbetan
  Shionogi Seiyaku, Japan



• Irbett
  Metlen, Colombia



• Irda
  Nobel, Turkey



• Iretensa
  Fahrenheit, Indonesia



• Irovel
  Sun, India



• Irtan Plus (Irbesartan and Hydrochlorothiazide)
  Ikapharmindo, Indonesia



• Irtan
  Ikapharmindo, Indonesia



• Irvask
  Kalbe, Indonesia



• Irvell
  Novell, Indonesia



• Isart
  ACI, Bangladesh



• Karvea
  Bristol-Myers Squibb, Germany; Bristol-Myers Squibb, Spain; Bristol-Myers Squibb, Greece; Bristol-Myers Squibb, Italy; Sanofi-Aventis, Australia; Sanofi-Aventis, Turkey



• Karvera
  Sanofi-Aventis, New Zealand



• Karvezide (Irbesartan and Hydrochlorothiazide)
  Bristol-Myers Squibb, Germany; Bristol-Myers Squibb, Spain; Bristol-Myers Squibb, Greece; Bristol-Myers Squibb, Italy; Brystol-Myers Squbb, Slovakia; Sanofi-Aventis, Australia



• Presartan
  Dr. Collado, Dominican Republic

International Drug Name Search

Glossary

BAN	British Approved Name
IS	Inofficial Synonym
OS	Official Synonym
PH	Pharmacopoeia Name
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
USAN	United States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.